価格表

在庫・価格 : 2025年05月02日 22時38分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
DRB <5, 6-Dichloro-1-β-D-Ribofuranosyl-1H-Benzimidazole>
データシート
10010302 CAYケイマン ケミカル
Cayman Chemical Company
10 mg ¥8,100
(未発注)
追加

在庫・価格 : 2025年05月02日 22時38分 現在

DRB <5, 6-Dichloro-1-β-D-Ribofuranosyl-1H-Benzimidazole>

  • 商品コード:10010302
  • メーカー:CAY
  • 包装:10mg
  • 価格: ¥8,100
  • 在庫:無(未発注)
参考文献
No. 文献情報 備考 参照
1 Rickert P et al. Cyclin C/CDK8 and cyclin H/CDK7/p36 are biochemically distinct CTD kinases. Oncogene 1999 Jan;18(4):1093-102
Rickert P et al
1999/01/01
PubMed
2 te Poele RH et al. RNA synthesis block by 5, 6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB) triggers p53-dependent apoptosis in human colon carcinoma cells. Oncogene 1999 Oct;18(42):5765-72
te Poele RH et al
1999/01/01
PubMed
3 Nam KA et al. Resveratrol analog, 3,5,2&#39;,4&#39;-tetramethoxy-trans-stilbene, potentiates the inhibition of cell growth and induces apoptosis in human cancer cells. Arch. Pharm. Res. 2001 Oct;24(5):441-5
Nam KA et al
2001/01/01
PubMed
4 Schang LM. Cyclin-dependent kinases as cellular targets for antiviral drugs. J. Antimicrob. Chemother. 2002 Dec;50(6):779-92
Schang LM
2002/01/01
PubMed
5 Marciniak RA et al. HIV-1 Tat protein promotes formation of more-processive elongation complexes. EMBO J. 1991 Dec;10(13):4189-96
Marciniak RA et al
1991/01/01
PubMed
6 Zandomeni RO. Kinetics of inhibition by 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole on calf thymus casein kinase II. Biochem. J. 1989 Sep;262(2):469-73
Zandomeni RO
1989/01/01
PubMed
7 Yankulov K et al. The transcriptional elongation inhibitor 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole inhibits transcription factor IIH-associated protein kinase. J. Biol. Chem. 1995 Oct;270(41):23922-5
Yankulov K et al
1995/01/01
PubMed
8 Yamaguchi Y et al. Interplay between positive and negative elongation factors: drawing a new view of DRB. Genes Cells 1998 Jan;3(1):9-15
Yamaguchi Y et al
1998/01/01
PubMed
  • No.: 1
  • 文献情報:
    Rickert P et al. Cyclin C/CDK8 and cyclin H/CDK7/p36 are biochemically distinct CTD kinases. Oncogene 1999 Jan;18(4):1093-102
    Rickert P et al
    1999/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    te Poele RH et al. RNA synthesis block by 5, 6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB) triggers p53-dependent apoptosis in human colon carcinoma cells. Oncogene 1999 Oct;18(42):5765-72
    te Poele RH et al
    1999/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Nam KA et al. Resveratrol analog, 3,5,2&#39;,4&#39;-tetramethoxy-trans-stilbene, potentiates the inhibition of cell growth and induces apoptosis in human cancer cells. Arch. Pharm. Res. 2001 Oct;24(5):441-5
    Nam KA et al
    2001/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Schang LM. Cyclin-dependent kinases as cellular targets for antiviral drugs. J. Antimicrob. Chemother. 2002 Dec;50(6):779-92
    Schang LM
    2002/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Marciniak RA et al. HIV-1 Tat protein promotes formation of more-processive elongation complexes. EMBO J. 1991 Dec;10(13):4189-96
    Marciniak RA et al
    1991/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Zandomeni RO. Kinetics of inhibition by 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole on calf thymus casein kinase II. Biochem. J. 1989 Sep;262(2):469-73
    Zandomeni RO
    1989/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Yankulov K et al. The transcriptional elongation inhibitor 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole inhibits transcription factor IIH-associated protein kinase. J. Biol. Chem. 1995 Oct;270(41):23922-5
    Yankulov K et al
    1995/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Yamaguchi Y et al. Interplay between positive and negative elongation factors: drawing a new view of DRB. Genes Cells 1998 Jan;3(1):9-15
    Yamaguchi Y et al
    1998/01/01
  • 備考:
  • 参照:
    PubMed